Seminar topic: Multi-Omic data for patient stratification and personalized medicine in immuno-inflammatory diseases

Vassili Soumelis was trained in Clinical Hematology and Immunology. His academic career started as a researcher-physician at the Institut Curie (2004-2018), followed by a Professor of Immunology (PUPH) position at Université Paris Cité and Hôpital St Louis. He made important contributions to the fields of human immunology, dendritic cell and T cell biology, cytokine biology, disease physiopathology, including HIV infection, allergy, autoimmunity and cancer. His academic research combines expertise in immunology, systems biology, computational biology, data science and medicine. 

In 2022 he joined Owkin, France, a HealthTech and Biotech company using artificial intelligence for personalized medicine, as their first Chief Medical Officer. Recently, he joined ArcaScience as Chief Medical Officer in order to spearhead the medical strategy of the company and contribute to the development of AI products to analyze, optimize and predict the risk-benefit of drugs and other therapeutic interventions. 

Vassili Soumelis coordinated a European FP6 Excellence Grant (2005-2009), coordinated bioinformatics and systems biology in the European consortium MAARS (FP7), and received ERC consolidator (IT-DC) and proof-of-concept (DrugSynergy) grants. He has been the global coordinator of the H2020 project ImmunAID, using multi-omics data integration for the diagnostic classification of rare auto-inflammatory diseases. 

V. Soumelis has published 144 scientific articles in international journals (h-index: 64). He has been serving as a reviewer for many research journals, including Nature, Immunity, Nature Immunology, Nature Genetics, Nature Computational Science, Nature Communications, the Journal of Experimental Medicine.

Mark your calendars and make sure to join!